Moderate Evidence
Research Overview
Oveporexton Research for Narcolepsy Type 2
An evidence-based overview of research examining Oveporexton in the context of narcolepsy type 2. This page synthesizes findings from peer-reviewed literature.
Research Summary
NT2 patients have excessive sleepiness without cataplexy and usually normal CSF orexin. ORCHESTRA-NT2 trial (NCT04808037) is ongoing to evaluate if OX2R agonism benefits this population with less clear orexin dysfunction.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Oveporexton may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.